Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
24.54
+0.46 (1.91%)
At close: Sep 18, 2025, 4:00 PM EDT
24.54
0.00 (0.00%)
After-hours: Sep 18, 2025, 4:04 PM EDT
Pharvaris Employees
Pharvaris had 108 employees as of December 31, 2024. The number of employees increased by 26 or 31.71% compared to the previous year.
Employees
108
Change (1Y)
26
Growth (1Y)
31.71%
Revenue / Employee
n/a
Profits / Employee
-$1,830,030
Market Cap
1.77B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 108 | 26 | 31.71% |
| Dec 31, 2023 | 82 | 17 | 26.15% |
| Dec 31, 2022 | 65 | 31 | 91.18% |
| Dec 31, 2021 | 34 | 20 | 142.86% |
| Dec 31, 2020 | 14 | 11 | 366.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PHVS News
- 8 days ago - Pharvaris N.V. (PHVS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 13 days ago - Pharvaris N.V. (PHVS) Presents at Wells Fargo 20th Annual Healthcare Conference 2025 Transcript - Seeking Alpha
- 14 days ago - Pharvaris N.V. (PHVS) Presents At Cantor Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 5 weeks ago - Pharvaris Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Pharvaris: Deucrictibant Advanced To Target Two Sets Of HAE Patient Populations - Seeking Alpha
- 2 months ago - Pharvaris Announces Pricing of Upsized $175 Million Public Offering of Ordinary Shares and Pre-Funded Warrants - GlobeNewsWire
- 2 months ago - Pharvaris Announces Proposed Public Offering of Ordinary Shares - GlobeNewsWire
- 2 months ago - Pharvaris: More Convenience, More Potency, And More Potential For Future HAE Success - Seeking Alpha